Combination cabozantinib and nivolumab treatment in patients with refractory metastatic renal cell carcinoma (mRCC)

被引：0

作者：

Kinsey, Emily ^{[1
]}

Brown, Landon ^{[1
]}

Kao, Chester ^{[1
]}

Healy, Patrick ^{[1
]}

Harrison, Michael ^{[1
]}

McNamara, Megan ^{[1
]}

Armstrong, Andrew ^{[1
]}

Ramalingham, Sundhar ^{[1
]}

George, Daniel ^{[1
]}

Zhang, Tian ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P526

引用

页数：1

共 3 条

[1] Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma [J].

Motzer, Robert J. ;

Penkov, Konstantin ;

Haanen, John ;

Rini, Brian ;

Albiges, Laurence ;

Campbell, Matthew T. ;

Venugopal, Balaji ;

Kollmannsberger, Christian ;

Negrier, Sylvie ;

Uemura, Motohide ;

Lee, Jae L. ;

Vasiliev, Aleksandr ;

Miller, Wilson H., Jr. ;

Gurney, Howard ;

Schmidinger, Manuela ;

Larkin, James ;

Atkins, Michael B. ;

Bedke, Jens ;

Alekseev, Boris ;

Wang, Jing ;

Mariani, Mariangela ;

Robbins, Paul B. ;

Chudnovsky, Aleksander ;

Fowst, Camilla ;

Hariharan, Subramanian ;

Huang, Bo ;

di Pietro, Alessandra ;

Choueiri, Toni K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (12) :1103-1115

[2]

Nadal R, 2017, ANN ONCOL, V28

[3]

Rini BI, 2019, NEW ENGL J MED

← 1 →